Yervoy User Reviews & Ratings
Yervoy has an average rating of 9.5 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Melanoma | 1 reviews for Melanoma | 13 medications | |
Melanoma, Metastatic | 1 reviews for Melanoma, Metastatic | 14 medications |
- D B...
- Taken for 1 to 6 months
- September 29, 2023
For Melanoma "Developed adrenal insufficiency, but it cured my melanoma."
See also:
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Lumakras
Lumakras is used to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC) or colorectal cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Mektovi
Mektovi (binimetinib) is an oral kinase inhibitor that may be used in combination with encorafenib ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Are you taking this medicine?
Your review helps others make informed decisions.More about Yervoy (ipilimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
For Melanoma, Metastatic "Two treatments in combination with OPDIVO, after the first treatment contracted sepsis, close to death but survived, after the second treatment (months apart), contracted colitis, a lot closer to death, told I had 2 days to live - spent 2 weeks in ICU. Six months later, regaining muscle, feeling stronger, cancer still in situ, but hopefully not life-threatening anymore, waiting on the latest PET/CT scans. Possibly keeping me alive, but it takes a toll on your body."